Gleiss Lutz advises Topcon on sale of majority interest in ifa systems AG

Gleiss Lutz has advised Topcon Europe Medical B.V., an indirect subsidiary of the Japanese Topcon Corporation, on the sale of its majority interest in ifa systems AG to Nexus AG.

Topcon is a Japanese manufacturer of optical devices for use in ophthalmology and optometrics, with around 4,450 employees worldwide. Topcon Corporation is listed on the Tokyo Stock Exchange.

ifa systems AG is one of the leading providers of software, IT services, web applications and medical information systems in the field of eye care. Headquartered in Frechen near Cologne, the company went public in 2005 and is currently listed in the Open Market segment (WKN 783078).

A team of Gleiss Lutz lawyers headed by Dr. Michael Burian (partner, corporate/M&A, Frankfurt), Dr. Stephan Aubel (partner, corporate/capital markets, Frankfurt, both lead), Dr. Martin Lembke (counsel) and Dr. Maike Sauter (all corporate/M&A, Stuttgart) advised Topcon on the transaction. The team also included Jan-Rasmus Roßkamp (corporate/capital markets, Frankfurt), Dr. Christopher Vogl (corporate/M&A, Stuttgart), Dr. Alexander Molle (partner) and Dr. Hannah Bug (both IP/IT, Berlin).

Gleiss Lutz previously assisted Topcon with its public acquisition offer for 50.1% of the shares in ifa systems AG in 2015. Gleiss Lutz’s Japan Advisory Group regularly advises Japanese companies on transactions in Germany and, among other things, most recently assisted Maruho in increasing its stake in Biofrontera AG as well as AEON in connection with a participation in Signa Sports United.